Does Dr. ABDULRAHMAN ABDULBAKI have financial conflicts of interest?

Dr. ABDULRAHMAN ABDULBAKI (MD) has received a total of $24,561 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $24,561 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ABDULRAHMAN ABDULBAKI?

According to CMS Open Payments data, Dr. ABDULRAHMAN ABDULBAKI received funding from ZOLL SERVICES (A/K/A ZOLL LIFECOR ) ($15,050), MEDTRONIC ($3,599), and BOSTON SCIENTIFIC CORPORATION ($1,470).

Does Dr. ABDULRAHMAN ABDULBAKI receive research grants or speaking fees?

Dr. ABDULRAHMAN ABDULBAKI has received $24,561 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ABDULRAHMAN ABDULBAKI

MDReal-Time Hydrated

Specialty: Internal Medicine, Interventional Cardiology

Practice Location: DES MOINES, IA 50309

NPI Number: 1972701050

LIFETIME INDUSTRY VALUE

$24,561

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABDULBAKI is a verified Internal Medicine, Interventional Cardiology practitioner based in DES MOINES, IA.

Between 2021 and 2024, Dr. ABDULBAKI had an overall industry promotional and research financial footprint of $24,561 as recorded in the federal CMS Open Payments database.

$24,561 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABDULBAKI's primary funding source is ZOLL SERVICES (A/K/A ZOLL LIFECOR ), which accounts for $15,050 (representing 61.3% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ZOLL SERVICES (A/K/A ZOLL LIFECOR )

Rank 1

$15,050

61.3%

MEDTRONIC

Rank 2

$3,599

14.7%

BOSTON SCIENTIFIC CORPORATION

Rank 3

$1,470

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.